Compiled here, all relevant comments and discussions regarding the AMRN stock. Please note that all comments included here have met Investing.com's Comment Guidelines.
1.25/30 soon…and 🚀🚀
There are some interesting articles and preprints on researchgate in regards to vascepa as a treatment for long covid
whats happend?
EU approval, nice
Holding April 30 6.50 strike call options for EU approval!
Amarin Corporation plc (NASDAQ: AMRN) announced that the Chinese Society of Cardiology has included icosapent ethyl in its updated ‘Guidelines for Primary Prevention of Cardiovascular Diseases for 2021'
$8 By Feb. 2021
nice call...where next?
nice call...where next?
https://www.globenewswire.com/news-release/2021/01/07/2154744/0/en/Amarin-Provides-Preliminary-2020-Results-and-2021-Outlook.html this is going to be a pleasant summer I would say
Yeaaah, a very slight wobble .. great u r ;-P
Had a slight wobble, I think still likely to be heading upwards.
Mr. Xin Ni: "VASCEPA has huge commercial potential in the fast-growing Chinese market. We will work with Amarin to submit the new drug application as soon as possible to bring this cross-era innovative drug to China.”
There were approximately 180.4 million hypertriglyceridemia (HTG) patients in China in 2019, representing approximately 20.2% of the adult population
I told you to switch with TEVA
lol $5.57
going to $20 again !?? I'm scared, very
what's causing stock to go down
hopefully stock goes up been beaten up for awhile now
It should go back at least above 7 because Vascepa generics did not lead to a decrease in sales, rather ... an increase? like if customers just want the most technological
... or that the demand is much higher than the supply
agreed!
My congratulations to Amarin for beating all earnings expectations in its third quarter
More important than the one below : --> VASCEPA® (ICOSAPENT ETHYL) FOUND TO SIGNIFICANTLY REDUCE CARDIOVASCULAR EVENTS IN PATIENTS WITH COMPROMISED RENAL FUNCTION AT BASELINE IN PRESPECIFIED AND POST HOC SUBGROUP ANALYSES OF LANDMARK REDUCE-IT® STUDY
This is meaningful:
https://www.globenewswire.com/news-release/2020/10/05/2103391/0/en/Latest-Research-Evaluating-VASCEPA-Icosapent-Ethyl-Mechanisms-of-Action-Presented-at-European-Atherosclerosis-Society-EAS-Congress-2020.html
OTOH VASCEPA is the original and genuine oil, not just a generic from small companies is it ok!?
This result is meaningful: https://www.globenewswire.com/news-release/2020/10/05/2103391/0/en/Latest-Research-Evaluating-VASCEPA-Icosapent-Ethyl-Mechanisms-of-Action-Presented-at-European-Atherosclerosis-Society-EAS-Congress-2020.html OTOH: VASCEPA is the original product and proce$$, not just a generic from small companies, is it ok!?
Amarin Corporation plc (NASDAQ: AMRN) announced that the Chinese Society of Cardiology has included icosapent ethyl in its updated ‘Guidelines for Primary Prevention of Cardiovascular Diseases for 2021'
0
$8 By Feb. 2021
0
nice call...where next?
0
nice call...where next?
0
https://www.globenewswire.com/news-release/2021/01/07/2154744/0/en/Amarin-Provides-Preliminary-2020-Results-and-2021-Outlook.html this is going to be a pleasant summer I would say
0
Yeaaah, a very slight wobble .. great u r ;-P
0
Had a slight wobble, I think still likely to be heading upwards.
Mr. Xin Ni: "VASCEPA has huge commercial potential in the fast-growing Chinese market. We will work with Amarin to submit the new drug application as soon as possible to bring this cross-era innovative drug to China.”
0
There were approximately 180.4 million hypertriglyceridemia (HTG) patients in China in 2019, representing approximately 20.2% of the adult population
0
I told you to switch with TEVA
0
lol $5.57
0
going to $20 again !?? I'm scared, very
0
what's causing stock to go down
0
hopefully stock goes up been beaten up for awhile now
0
It should go back at least above 7 because Vascepa generics did not lead to a decrease in sales, rather ... an increase? like if customers just want the most technological
0
... or that the demand is much higher than the supply
0
agreed!
0
My congratulations to Amarin for beating all earnings expectations in its third quarter
0
More important than the one below : --> VASCEPA® (ICOSAPENT ETHYL) FOUND TO SIGNIFICANTLY REDUCE CARDIOVASCULAR EVENTS IN PATIENTS WITH COMPROMISED RENAL FUNCTION AT BASELINE IN PRESPECIFIED AND POST HOC SUBGROUP ANALYSES OF LANDMARK REDUCE-IT® STUDY
This is meaningful:
https://www.globenewswire.com/news-release/2020/10/05/2103391/0/en/Latest-Research-Evaluating-VASCEPA-Icosapent-Ethyl-Mechanisms-of-Action-Presented-at-European-Atherosclerosis-Society-EAS-Congress-2020.html
OTOH VASCEPA is the original and genuine oil, not just a generic from small companies is it ok!?
1
This result is meaningful: https://www.globenewswire.com/news-release/2020/10/05/2103391/0/en/Latest-Research-Evaluating-VASCEPA-Icosapent-Ethyl-Mechanisms-of-Action-Presented-at-European-Atherosclerosis-Society-EAS-Congress-2020.html OTOH: VASCEPA is the original product and proce$$, not just a generic from small companies, is it ok!?